Condition: Chronic Hepatitis b · Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Chronic hepatitis B virus (HBV) infection remains a global public health burden around the world. Investigating the disease process of chronic hepatitis B (CHB) is essential to individual management in clinical practice. According to American Association for the Study of Liver Diseases (AASLD) 2018 Hepatitis B Guidance, CHB can be classified into four phases: immune-tolerant CHB, HBeAg-positive immune active CHB, inactive CHB and hepatitis B e antigen (HBeAg)-negative immune active CHB. Antiviral therapy is recommended in patients with HBeAg-positive or -negative immune active CHB patients to reduce the incidence of liver cirrhosis and hepatocellular carcinoma, while periodic monitoring is recommended for inactive carrier and immune-tolerant CHB patients. However, a substantial proportion of patients fall into an indeterminate phase whose serum HBV DNA and alanine aminotransferase levels do not fit well into these well-described phases. Most of CHB patients with indeterminate phase are HBeAg negative. However, the clinical outcomes of these patients remain unclear. Therefore, the purpose of this study is to investigate the clinical outcomes of HBeAg-negative chronic hepatitis B patients with indeterminate phase.
This description comes directly from the study's public registry record.
Chao Wu, M.D., Ph.D · 86-25-83105890 · dr.wu@nju.edu.cn
Rui Huang, M.D., Ph.D · doctor_hr@126.com
Always discuss trial participation with your own doctor first.
| The Third Hospital of Changzhou | Changzhou, Jiangsu, China | Recruiting |
| Huai'an No.4 People's Hospital | Huai'an, Jiangsu, China | Recruiting |
| Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School | Nanjing, Jiangsu, China | Recruiting |
| Suqian People's Hospital | Suqian, Jiangsu, China | Recruiting |
| The Fifth People's Hospital of Suzhou | Suzhou, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05661786